Endocrine Abstracts

Patients with diabetes mellitus (DM) type 2 is a group of high cardiovascular risk. The incidence of coronary heart disease in their 2–4 times higher than in the population without diabetes, 80% of cases of diabetes combined with hypertension. At the same time any change in lipid metabolism leads to increased cardiovascular risk in patients with type 2 diabetes. Statins is first-line drugs in patients with dyslipidemia.Materials and methods: The stu...

Today, there are 382 million people living with diabetes. The overwhelming majority have a type 2 diabetes. Metformin is first-line drug is for many of them.Materials and methods: The study involved 26 patients in mean age 54.46±1.2 years (from 41 to 65), among them, 14 women and 12 men. 21 patients with newly diagnosed diabetes and five patients receiving treatment with sulfonylureas. All patients were prescribed metformin in mean dose 2000 mg. Dur...

Introduction: The objective of the research was to determine the predictive value of the most probable etiopathogenetic factors contributing to the development and progression of gastric dysfunction in patients with type 2 diabetes. Only 5% of type 1 and 1% of type 2 diabetic combine the delay of gastric emptying (DGE) with typical gastroparesis symptoms. Systematic review of risk factors of development and progression symptoms of diabetic gastroparesis (DG). Results presented...